Skip to main content
. 2017 Sep 8;17:179. doi: 10.1186/s12883-017-0955-6

Table 1.

The schedule of follow-up of study

Screening Follow up
1st screening BM hervest 2nd screening Pre-administration Post-administration
Onset to14 days Day −7 (±1) Day 0 Day 1 Day 3 Day 7 Day 14 Day 30 (±3) Day 90 (±30) Day 180 (±30) Day 360 (±30)
Informed consent X
Medical history X
Vital signs X X X X X X X X X X X X X
Body weight and height X
Serological tests X X X X X X X X X X X
Biochemical tests X X X X X X X X X X X
Urinalysis X X X X X X
Urine hCG-β (If needed) X X X X X
Infectious disease inspection X
12-lead electrocardiogram X X X X X X X
Chest X-ray examination X X X X X X X
Neurological examination X X X X X X X X
MRI X X X X X X X X X X X
FDG-PET and IMZ-SPECT X X X X
Bone marrow harvest X
Cell product administration X
Concomitant medication X X X X X X X X X X X X X
Adverse events X X X X X X X X X X X X X